Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Respir J. 2012 Feb;39(2):429-38. doi: 10.1183/09031936.00197810. Epub 2011 Aug 4.

Clara cells drive eosinophil accumulation in allergic asthma.

Author information

  • 1Institute of Integrative Biology, Molecular Biomedicine, ETH Zurich, Wagistrasse 27, 8952 Schlieren-Zurich, Switzerland. sanchaita.sonar@env.ethz.ch

Abstract

Development of allergic asthma is a complex process involving immune, neuronal and tissue cells. In the lung, Clara cells represent a major part of the "immunomodulatory barrier" of the airway epithelium. To understand the contribution of these cells to the inflammatory outcome of asthma, disease development was assessed using an adjuvant-free ovalbumin model. Mice were sensitised with subcutaneous injections of 10 μg endotoxin-free ovalbumin in conjunction with naphthalene-induced Clara cell depletion. Clara epithelial cell depletion in the lung strongly reduced eosinophil influx, which correlated with decreased eotaxin levels and, moreover, diminished the T-helper cell type 2 inflammatory response, including interleukin (IL)-4, IL-5 and IL-13. In contrast, airway hyperresponsiveness was increased. Further investigation revealed Clara cells as the principal source of eotaxin in the lung. These findings are the first to show that Clara airway epithelial cells substantially contribute to the infiltration of eotaxin-responsive CCR3+ immune cells and augment the allergic immune response in the lung. The present study identifies Clara cells as a potential therapeutic target in inflammatory lung diseases such as allergic asthma.

PMID:
21828027
DOI:
10.1183/09031936.00197810
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center